VIR Q2 2021 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$177M+167.2% YoY

Gross Profit

$90M50.7% margin

Operating Income

$61M34.5% margin

Net Income

$62M34.9% margin

EPS (Diluted)

$0.46

QoQ Revenue Growth

+29167.4%

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

$138M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$320M

Stockholders' Equity

$737M

Cash & Equivalents

$742M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$177M	$66M	+167.2%
Gross Profit	$90M	$66M	+35.5%
Operating Income	$61M	-$29M	+310.0%
Net Income	$62M	-$31M	+298.3%

Revenue Segments

Collaboration Revenue

$5M100%